BIT 3.03% 3.4¢ biotron limited

Ann: Biotron to Test its Compounds Against Coronavirus, page-929

  1. 486 Posts.
    lightbulb Created with Sketch. 180
    https://www.biorxiv.org/content/10.1101/2020.06.27.174953v1.full.pdf

    Cytokine storm and consequent acute respiratory distress syndrome (ARDS) characterized by dysfunctional immune responses and severe pulmonary injury are the main causes of SARS-CoV-2-related death(Guan et al., 2020; Mehta et al., 2020; Zhang et al., 2020).

    And sorry to keep banging on about it, but here is our old friend the 'E' protein.

    Here we show that the SARS-CoV-2 envelope (2-E) protein alone is sufficient to cause acute respiratory distress syndrome (ARDS)-like damage in vitro and in vivo. Over expression of 2-E protein induced rapid pyroptosis-like cell death in various susceptible cells and robust secretion of cytokines and chemokines in macrophages.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.001(3.03%)
Mkt cap ! $30.67M
Open High Low Value Volume
3.4¢ 3.4¢ 3.3¢ $632 18.85K

Buyers (Bids)

No. Vol. Price($)
1 287617 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 37989 2
View Market Depth
Last trade - 13.36pm 19/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.